Location History:
- Ft. Worth, TX (US) (2014)
- Fort Worth, TX (US) (2016)
Company Filing History:
Years Active: 2014-2025
Title: Inventor Andras G. Lacko: Pioneering Advances in Drug Delivery Systems
Introduction
Andras G. Lacko is an innovative inventor based in Fort Worth, Texas, whose work has significantly impacted the fields of nanotechnology and drug delivery systems. With a total of three patents, his research focuses on enhancing radio-imaging applications and developing targeted drug delivery vehicles to treat various diseases.
Latest Patents
Andras G. Lacko's latest patents reflect his commitment to advancing medical technologies. One of his notable inventions is the "Reconstituted HDL nanoparticles for delivery of radioactive agents and uses thereof." This groundbreaking patent addresses the limited attention given to lipoprotein-based delivery systems in the realm of nanotechnology. The application outlines the synthesis of a novel hydrophobic radio-imaging tracer composed of a hydrazinonicotinic acid (HYNIC)-N-dodecylamide and technetium-99m (mTc) conjugate, which can be encapsulated into rHDL nanoparticles (NPs). These rHDL NPs effectively target the Scavenger Receptor type B1 (SR-B1), commonly overexpressed on cancer cells due to their increased cholesterol demand for membrane biogenesis, thereby enabling targeted tumor imaging in vivo. In addition, he has developed a drug delivery vehicle that comprises compositions with targeted poly-amino-acid subunits, offering methods of manufacture and treatment approaches for various diseases.
Career Highlights
Andras G. Lacko has made significant contributions to his field during his tenure at institutions like the University of North Texas and the University of Texas System. His work is renowned for its focus on applying nanotechnology in medical applications, particularly in the area of cancer treatment, showcasing his innovative spirit and dedication to advancing scientific research.
Collaborations
Throughout his career, Andras has collaborated with several notable professionals, including Laszlo Prokai and Anil K. Sood. These partnerships have enriched his research initiatives and contributed to the development of innovative solutions in drug delivery and bio-imaging.
Conclusion
As a dedicated inventor, Andras G. Lacko continues to be a key player in advancing the field of nanotechnology and drug delivery systems. His pioneering patents and collaborations underline his commitment to improving medical outcomes through innovative research. With continued exploration and development in these areas, he is sure to inspire further advancements in the medical and pharmaceutical industries.